Drug Usage Statistics, United States, 2007 - 2017

Number of Prescriptions Over Time (2007 - 2017)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2008 476 -
2009 314  162
2010 214  100
2011 180  34
2012 171  9
Year Rank Change
2013 183  12
2014 200  17
2015 238  38
2016 272  34
2017 235  37

Patient Out-Of-Pocket Cost Over Time (2007 - 2017)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Name Total Prescriptions (2017)
Duloxetine 16,512,764
Venlafaxine 16,080,521
Desvenlafaxine (this drug) 2,111,927

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Khedezla
  • Desvenlafaxine
  • Pristiq
Generic Drug Synonyms and Salts
  • Desvenlafaxine Fumarate
  • Desvenlafaxine Fumarate Monohydrate
  • Desvenlafaxine Succinate
  • Desvenlafaxine

FDA Approval Information

Established Pharmacologic Class (EPC): Serotonin and Norepinephrine Reuptake Inhibitor
Initial FDA approval date: 2/29/2008
First FDA applicant: Rx
First dosage form: Tablet, Extended Release (oral)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2007-2017. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 20.1. Read more about the ClinCalc DrugStats database.


Related Links

Follow Us!

New and Popular


Open Menu

Cite This Page

Show AMA citation

©2020 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Jul 19, 2018
Back to Top